Cadrenal Therapeutics, Inc. (CVKD) stock
CVKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.72−0.16 (-8.51%)
Close on Nov 18, 2026Market cap $6.14MP/E –Yield 959.30%
Cadrenal Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Cadrenal Therapeutics's price to book ratio was 1.1× on Nov 11, 2026, against 7.1× a year earlier. Over the last 4 years it ranged from 0.7× to 7.2×, with a median of 3.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.1× | −4.0 |
| 2025 | Dec 31, 2025 | 5.1× | −0.1 |
| 2024 | Dec 31, 2024 | 5.2× | +4.1 |
| 2023 | Dec 29, 2023 | 1.1× | – |
See a number that looks wrong?